In response, blocking IL-6 receptor (IL-6R) with specific antibody not only inhibited the expression of KIAA1199 in RA FLS (Fig. 6E, F), but also reduced the formation of LMW-HA in the medium (Fig. 6G). The gene discussed is CEMIP; the disease is rheumatoid arthritis.